Genosomes: An Introspection into Transfection, Future Perspectives and Applications

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Molecular Biology

Background:

• Gene therapy utilizes nucleic acids (miRNA, siRNA, pDNA) to treat genetic diseases.
• Viral vectors are traditional but have safety and immunogenicity concerns.
• Non-viral genosomes (cationic lipid-based nanocarriers) offer improved biosafety and manufacturability.

Purpose of the Study:

• To critically analyze genosome design, formulation, and delivery mechanisms.
• To review clinical applications and patented innovations in genosome-mediated gene therapy.
• To explore future prospects for advancing genosome-based therapeutics.

Main Methods:

• Review of scientific literature on genosome technology.
• Analysis of nanostructure design and formulation strategies.
• Examination of intracellular trafficking and transfection efficiency.

Main Results:

• Genosomes efficiently condense and protect nucleic acids, enhancing cellular uptake and endosomal escape.
• Refinements like PEGylation and stimuli-responsive formulations improve delivery.
• Clinical advancements show promise in areas like cancer immunotherapy.

Conclusions:

• Genosomes represent a promising, safer alternative to viral vectors for gene therapy.
• Optimized genosome design and formulation are key to enhancing therapeutic efficacy.
• Further research and development are crucial for realizing the full potential of genosome-mediated gene therapy.